The Clorox Company
CLX · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 7.11B | 2.55B | 719.00M | 462.00M | 3.75 |
| 2023 FY | 7.39B | 2.91B | 823.00M | 149.00M | 1.21 |
| 2024 FY | 7.09B | 3.05B | 723.00M | 280.00M | 2.25 |
| 2025 FY | 7.10B | 3.21B | 1.18B | 810.00M | 6.56 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 6.16B | 5.43B | 183.00M | 3.10B | 556.00M |
| 2023 FY | 5.95B | 5.56B | 367.00M | 2.92B | 220.00M |
| 2024 FY | 5.75B | 5.26B | 202.00M | 2.90B | 328.00M |
| 2025 FY | 5.56B | 5.08B | 167.00M | 2.88B | 321.00M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 786.00M | -251.00M | 535.00M | -571.00M | -138.00M |
| 2023 FY | 1.16B | -228.00M | 930.00M | -583.00M | 184.00M |
| 2024 FY | 695.00M | -212.00M | 483.00M | -595.00M | -161.00M |
| 2025 FY | 981.00M | -220.00M | 761.00M | -602.00M | -35.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 17.36B | 20.28B | — | — | — |
| 2023 FY | 19.66B | 22.21B | — | — | — |
| 2024 FY | 16.67B | 19.37B | — | — | — |
| 2025 FY | 14.83B | 17.54B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2027-06-30 | — | — | — | — | — |
| 2028-06-30 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q4 | 1.99B | 924.00M | 420.00M | 332.00M | 2.70 |
| 2026 Q1 | 1.43B | 596.00M | 120.00M | 80.00M | 0.65 |
| 2026 Q2 | 1.67B | 722.00M | 236.00M | 157.00M | 1.29 |
| 2026 Q3 | 1.67B | 722.00M | 284.00M | 187.00M | 1.54 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q4 | 5.56B | 5.08B | 167.00M | 2.88B | 321.00M |
| 2026 Q1 | 5.53B | 5.39B | 166.00M | 3.08B | -22.00M |
| 2026 Q2 | 5.61B | 5.58B | 227.00M | 3.22B | -125.00M |
| 2026 Q3 | 6.44B | 6.34B | 1.19B | 4.49B | -67.00M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q4 | 294.00M | -75.00M | 219.00M | -150.00M | -59.00M |
| 2026 Q1 | 93.00M | -36.00M | 57.00M | -151.00M | -1.00M |
| 2026 Q2 | 311.00M | -42.00M | 269.00M | -151.00M | 60.00M |
| 2026 Q3 | -122.00M | -43.00M | -165.00M | -150.00M | 958.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q4 | 14.79B | 17.50B | — | — | — |
| 2026 Q1 | 15.12B | 18.03B | — | — | — |
| 2026 Q2 | 12.26B | 15.25B | — | — | — |
| 2026 Q3 | 12.58B | 15.88B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |